Krystle Spurling, LPN | |
2715 Lilac St, Longview, WA 98632-3526 | |
(360) 575-7676 | |
Not Available |
Full Name | Krystle Spurling |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 2715 Lilac St, Longview, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356874846 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 60060890 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Krystle Spurling, LPN 2715 Lilac St, Longview, WA 98632-3526 Ph: () - | Krystle Spurling, LPN 2715 Lilac St, Longview, WA 98632-3526 Ph: (360) 575-7676 |
News Archive
Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks in the brain which control sleep, providing knowledge which in the future may in the long term help the many Danes large proportion of people who experience problems sleeping.
Kidney specialists, or nephrologists, care for a medically complex population and frequently must discuss serious news with patients: giving a diagnosis of kidney disease, explaining the risks and benefits of treatments, and defining care goals at the end of life. Yet nephrologists do not routinely receive formal education on how to engage in these types of conversations.
Seattle Children's today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, one of the deadliest forms of childhood cancer.
› Verified 3 days ago